baber/WOPTO huggingface dataset:
Patent EP-1663501-A2 (EP)
Inventor: SCATTERGOOD JOHN R
IPC: B22F9/10
Filed: 2004-09-08
Abstract: L'invention porte sur un nouveau procédé permettant d'atomiser une substance liquide ou un mélanges de substances liquides. Cette invention porte notamment sur la technique consistant à utiliser des forces d'inertie générées dans un environnement d'accélération élevée afin de miniaturiser également et améliorer les caractéristiques des particules résultant de l'atomisation. Le but de cette invention est de soumettre une substance fondue à une accélération élevée et de faire passer un fluide sur la surface de la matière fondue. Le but d'avoir une accélération élevée est d'accroître l'importance relative des forces gravitationnelles dans la matière fondue, ce qui miniaturise toute perturbation influencée par la gravité. Cet environnement d'accélération élevée conduit à la miniaturisation des phénomènes dépendant de la gravité et entraîne la génération de particules plus petites. Le but du fluide d'atomisation est de conférer une énergie cinétique à la matière fondue, ce qui génère des perturbations, et d'agir comme un milieu de transfert thermique pour refroidir les particules. En d'autres termes, cette invention porte non seulement sur l'utilisation de l'éclatement des bulles, des ondes de  surface et des éclaboussures pour générer de fines particules en introduisant spécialement un flux gazeux sur la ou les substances liquides à atomiser, mais aussi sur l'amélioration du procédé pour que ces substances liquides soient simultanément à une accélération élevée. D'autres modes de mise en oeuvre de cette invention permettent d'améliorer considérablement les caractéristiques physiques des particules obtenues, en permettant de produire des particules plus petites, en refroidissant les particules plus rapidement et en réduisant les menaces de contamination en évitant le contact physique entre la ou les substances à atomiser et tous matériaux réfractaires.
Patent EP-1634305-A2 (EP)
Title: Procede de fabrication de resistance a couche mince a tcr 0
Inventor: AMADON JEFFREY R
IPC: H01C7/06
Filed: 2004-05-26
Abstract: L'invention concerne une résistance en couche mince dont le TCR est sensiblement égal à zéro, ainsi qu'un procédé de fabrication associé. La résistance à couche mince comporte au moins deux matériaux de résistance placés l'un au-dessus de l'autre. Chaque matériau de résistance présente un coefficient de température de résistivité différent, de sorte que le coefficient de température de résistivité efficace de la résistance à couche mince est sensiblement égal à 0 ppm/ °C. La résistance à couche mince peut s'intégrer dans une structure d'interconnexion ou avec un condensateur métal-isolant-métal (MIMCAP).
Patent EP-1694829-A2 (EP)
Inventor: VAN DER WERF SYLVIE
IPC: G01N33/569
Filed: 2004-12-02
Abstract: An isolated and purified strain of human coronavirus (CV) associated with severe acute respiratory syndrome (SARS), is new. Isolated and purified strain of human coronavirus (CV) associated with severe acute respiratory syndrome (SARS). Its genome, in the form of cDNA, includes a Ser codon at positions 23220-23222 of the S protein or a Gly codon at positions 25298-25300 of the ORF3 gene, and an Ala codon at positions 7918-7920 of ORF1a or a Ser codon at positions 26857-26859 of the protein M gene, where all positions are referenced to the Genbank sequence AY27419.3. Independent claims are also included for: (1) isolated or purified polynucleotide (I) from the genome of the new strain; (2) isolated or purified polynucleotide (Ia) that hybridizes to (I) under highly stringent conditions; (3) fragments of (I) or (Ia); (4) pairs of primers that can amplify part of the genome of CV, or its equivalent DNA; (5) probes that can detect the genome of CV, or part of it; (6) DNA or RNA chips or filters that contain at least one of (I), (Ia) or their fragments; (7) recombinant cloning and/or expression vector that contains a fragment of (3); (8) cDNA bank that comprises the fragments of (3); (9) cells modified by the vector of (7) or the bank of (8); (10) isolated, purified protein or peptide (II) that is encoded by (I), (Ia) or their fragments; (11) mono- or poly-clonal antibodies (Ab), or their fragments, prepared by immunization with the vector of (7), the bank of (8) or (II), and able to bind to at least one (II); (12) protein or peptide chip or filter that includes at least one (II), Ab or fragment of Ab; (13) detection reagent for a SARS-associated CV that contains the new primers, probes, chips, filters, vectors, CV strain, (I), (Ia), (II), Ab or its fragments; (14) detecting CV by amplifying, from material extracted from a sample, a fragment of ORF-N by reverse transcription PCR, using the primers of (4), then detecting any amplicon formed; and (15) kit for detection of CV comprising any of the new primers, probes, DNA/RNA chips or filters, vectors, cells, isolated CV, (I) or (Ia). ACTIVITY : Virucide. No biological data given. MECHANISM OF ACTION : Vaccine.
Patent EP-1670417-A2 (EP)
Inventor: STEPHENSON DIANE T
IPC: A61K31/19
Filed: 2004-10-04
Abstract: La présente invention concerne des méthodes et des compositions permettant de traiter le ralentissement du débit sanguin vers le système nerveux central. La méthode décrite dans cette invention consiste à administrer, à un sujet, une composition comprenant un inhibiteur sélectif de la cyclooxygénase-2 et, conjointement, à placer ledit sujet dans un état d'hypothermie, de manière à obtenir une fonction neurologique améliorée chez des sujets présentant une lésion du système nerveux central induite par une ischémie, y compris, un accident vasculaire cérébral, un traumatisme cérébral et une lésion médullaire.
Patent EP-1691732-A2 (EP)
Inventor: MALEK MICHEL
IPC: A61F2/44
Filed: 2004-11-23
Abstract: L'invention concerne des éléments de stabilisation rachidienne et des systèmes de stabilisation rachidienne constitués d'éléments de stabilisation rachidienne combinés à des prothèses formant disque et à des remplacements de noyau formant disque. Ces éléments de stabilisation et ces systèmes de stabilisation sont conçus pour conserver une mobilité naturelle des disques vertébraux et des articulations à facettes, chez des patients présentant une maladie d'articulation à facettes, ou chez des patients ayant subi une procédure de déstabilisation antérieure, notamment une facettectomie. Les éléments de stabilisation de l'invention peuvent être des éléments pivotants ou des éléments dynamiques.
Patent EP-1733529-A2 (EP)
Inventor: MCALLEN CHRISTOPHER M
IPC: G16H10/60
Filed: 2004-12-01
Abstract: La présente invention concerne un système et un procédé destinés à détecter si un dispositif médical est connecté à un réseau, à établir une communication sécurisée entre un serveur et le dispositif médical, et à communiquer avec le dispositif médical. L'invention concerne également un procédé de chiffrement permettant d'assurer des communications sécurisées dans le réseau entre un serveur et des dispositifs médicaux connectés au réseau. Cette invention concerne en outre un système et un procédé destinés à déterminer l'emplacement de dispositifs médicaux dans une institution.
Patent EP-1704263-A2 (EP)
Title: Alliages au cobalt ductiles a phase de laves
Inventor: WU JAMES B C
IPC: C22C19/07
Filed: 2004-12-17
Abstract: L'invention porte sur un alliage de Co-Mo-Cr et sur des revêtements anti usure et anti corrosion. Le rapport Mo:Si est compris entre environ 15:1 et environ 22:1 pour permettre d'accroître la ductilité du fait de la présence d'une une phase de Laves.
Patent EP-1568742-A2 (EP)
Inventor: NAKANO YUKIHIRO
IPC: C09D11/00
Filed: 2001-05-23
Abstract: A water-based ink composition comprising (A) an aqueous medium; (B)
at least one colorant selected from the group consisting of (i) polymer particles
comprising a dye or pigment and a water-insoluble polymer, and (ii) a self-dispersible
pigment; and (C) a specific compound A. The water-based ink
composition is used for inkjet printing.
Patent EP-1580631-A2 (EP)
Inventor: STARON RAYMOND J
IPC: G06Q10/00
Filed: 2005-03-24
Abstract: A controller capable of being employed in a distributed control system, where the
distributed control system controls operations of a plurality of devices that operate together to
perform a process, and a method of communicating information between a first program portion
and a second program portion of such a controller, are disclosed. The controller includes at
least one processing component configured to perform a first plurality of program portions that
operate in relation with one another as a first agent. The plurality of program portions includes
a first program portion that controls agent-type behavior of the controller, and a second program
portion that at least one of controls and monitors at least one of the devices. The controller
further includes at least one memory component that stores a data table that is accessed by each
of the first and second program portions to allow communication between those program
portions.
Patent EP-1564800-A2 (EP)
Inventor: KONUMA TOSHIMITSU
IPC: H01L21/321
Filed: 1994-09-20
Abstract: A TFT formed on an insulating substrate source, drain and channel
regions, a gate insulating film formed on at least the channel region and a
gate electrode formed on the gate insulating film. Between the channel
region and the drain region, a region having a higher resistivity is
provided in order to reduce an Ioff current. A method for forming this
structure comprises the steps of anodizing the gate electrode to form a
porous anodic oxide film on the side of the gate electrode; removing a
portion of the gate insulating using the porous anodic oxide film as a mask
so that the gate insulating film extends beyond the gate electrode but does
not completely cover the source and drain regions. Thereafter, an ion
doping of one conductivity element is performed. The high resistivity
region is defined under the gate insulating film.
Patent EP-1594096-A2 (EP)
Inventor: INAMURA YUKINORI
IPC: G07F17/34
Filed: 2005-04-25
Abstract: A gaming machine on which the player can freely set an activated pay
line is provided. The game player may identify the pay line by touching any of
stop areas for display five times via a touch panel (S101: YES) such that the
player can choose the activated pay line (S102-S110). Therefore, the player
can freely set the activated pay line with any combinations. Also, after such
identified pay line is determined whether it can be set or not (S103: YES), it is
set as the activated pay line (S110) and a prescribed gaming characteristics
may be retained.
Patent EP-1562293-A2 (EP)
Inventor: CALDWELL DAVID W
IPC: H03K17/96
Filed: 1997-12-08
Abstract: A sensor apparatus for generating a control signal on a sense line (24), said apparatus
comprises at least one first electrode (16) and at least one second electrode (18)
positioned in proximity to said first electrode. A circuit has first and second input
nodes connected to said first and second electrodes (16,18), respectively, and an
output node connected to said sense line (24). A signal source (60) provides electrical
signals to said first and second electrodes (16, 18). An electric field is generated
between said first and second electrodes (16,18) in response to the signals provided to
at least one of said first and second electrodes (16,18) by said signal source (60).
Said first and second electrodes (16,18) are arranged such that the electric field is
disrupted by the presence of a stimulus in proximity to at least one of said first and
second electrodes (16,18). Said circuit generates a control signal on said sense line
(24) related to the difference in electrical potential between said first and second
electrodes (16,18) caused by the disruption to the electric field.
Patent EP-1598665-A2 (EP)
Inventor: SUKEDA MASAMI
IPC: G01N29/265
Filed: 2005-05-11
Abstract: A method of connecting hollow conductors with a brazing
alloy employs a measuring mechanism 10 for measuring a
connecting state of a connecting portion after brazing hollow
conductors. The measuring mechanism comprises a scanner 101 and
a holder 19, which are separated in advance, so that the
mechanism can be installed in a narrow space. A display
mechanism 20 displays measuring results as tow-dimensional
patterns, and the evaluation mechanism 30 evaluate the
connecting portions by an area of the defects and an integral
length of sound portions. A judgment mechanism 40 evaluates
relative relation of the measuring results with
causes-and-defects, which are previously stored, and shows the
cause of the defect.
Patent EP-1600929-A2 (EP)
Inventor: YASUOKA YOZO
IPC: G09G3/36
Filed: 2005-05-25
Abstract: The color liquid crystal display device includes a
transflective liquid crystal display panel (1), a frontlight
(2) arranged on a surface of the liquid crystal display
panel, the frontlight (2) including a front-side light source (73)
for emitting light having three primary colors, a
backlight (3) arranged on a back side of the liquid crystal
display panel (1), the backlight (3) including a back-side light
source (53) for emitting light having three primary colors, a
controller for controlling the front-side light source (73)
and the back-side light source such that light emitted
from the front-side light source and the back-side light
source is irradiated onto the liquid crystal display
panel (1) as alternating light, and a control circuit for
controlling display of the liquid crystal display panel
in synchronization with the alternating light.
Patent EP-1642987-A2 (EP)
Inventor: MONCANY MAURICE
IPC: C12Q1/68
Filed: 1990-06-05
Abstract: Oligonucleotide (I), comprising a specific sequence (A) of the gene gag or gene pol, and susceptible to hybridize at 60[deg]C+-1[deg]C with the genomes of viruses HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 Rod or SIV Mac; or a sequence complementary to a sequence (A), is new. Independent claims are also included for: (1) couple of oligonucleotide primers (II), for carrying out a gene amplification of the gene gag or gene pol of the virus of the type HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 Rod or SIV Ma, where the primers consists each one of: a specific sequence of the gene gag or gene pol, and susceptible to hybridize at 60[deg]C+-1[deg]C with the genomes of viruses HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 Rod or SIV Mac; or a sequence complementary to the sequence (A); (2) a process of gene amplification of nucleic sequences of the gene gag or the gene pol of virus of type (HIV-1 and/or HIV-2, and/or SIV, from a biological sample, comprising: (a) a stage of extraction of the nucleic acid to be detected belonging to the genome of the virus of the HIV-1 type, HIV-2 or SIV, optionally present in the biological sample, and optionally a stage of treatment using a reverse transcriptase of the nucleic acid if the latter is in the form of RNA; (b) a cycle comprising: denaturation of the double stranded nucleic acid to be detected, which leads to the formation of a single strand nucleic acid, hybridization of each strand of nucleic acid, obtained at the stage of denaturation, with at least a primer or a couple of primers of (II), by setting in contact the strands with at least a couple of the primers, formation from primers, of complementary DNA strands on which they are hybridized in the presence of a DNA polymerase and four different nucleosides triphosphate (NTP), which leads to the formation of a greater number of double strand nucleic acid to be detected at the stage of preceding denaturation, and repetition of the cycle for a determined number of times to obtain the nucleic sequence to be detected optionally present in the biological sample in a proportion sufficient to allow its detection; and (c) a stage of detection of the optional presence of the nucleic acid belonging to the genome of the virus in the biological sample; and (3) a kit for carrying out the process of gene amplification of nucleic sequences of the gene gag or the gene pol of virus of type (HIV-1 and/or HIV-2, and/or SIV, from a biological sample, comprising: at least a primer or a couple of oligonucleotidic primers of (II); reagents appropriate to be used in cycle of amplification, in particular DNA polymerase, four different nucleotide triphosphate, and buffer 10X; and one (or several) probe, can be marked, capable of hybridizing with the amplified sequence of nucleic acid to be detected.
Patent EP-1604658-A2 (EP)
Inventor: PANKHANIA MAHENDRA GOVIND
IPC: A61K31/54
Filed: 2002-04-10
Abstract: A pharmaceutical composition for the treatment of migraine or overindulgence
comprising a therapeutically effective amount of racemic ibuprofen or a
pharmaceutically acceptable salt or an enantiomer or a pharmaceutically
acceptable salt thereof and a therapeutically effective amount of
prochlorperazine or a pharmaceutically acceptable salt thereof.
Patent EP-1650883-A2 (EP)
Inventor: OH HYUN-SEOK
IPC: H04J99/00
Filed: 2005-10-21
Abstract: An apparatus and method are provided for transmitting and receiving high-speed packet data without path loss in a mobile communication system with a plurality of transmitting and receiving antennas. To support high-speed data for a mobile station (MS), a base station (BS) identifies a correlation between the number of transmitting antennas and the number of receiving antennas using feedback information and determines whether to establish a relay transmission scheme. The BS determines if quality of service for the MS is satisfied when the number of transmitting antennas is grater than the number of receiving antennas according to the established relay transmission scheme. When the quality of service for the MS is not satisfied, the BS transmits the high-speed data through a specific node group adjacent to the MS.
Patent EP-1639991-A2 (EP)
Inventor: SCHLACHTER HERBERT
IPC: A23L1/305
Filed: 1999-07-15
Abstract: A composition (I) containing (a) at least one salt selected from alkali metal salts, alkaline earth metal salts and other minerals, additionally contains (b) at least one aminoacid and (c) zinc oxide and/or an inorganic peroxide. ACTIVITY : Dermatological; antipsoriatic; antirheumatic; cytostatic; gastrointestinal. MECHANISM OF ACTION : (I) promotes diffusion of ions through ion channels into the intracellular space to improve microcirculation.
Patent EP-1674319-A2 (EP)
Inventor: SEIFERT JOCHEN
IPC: B60K15/06
Filed: 2005-12-06
Abstract: The system has at least two tanks (1,2) connected via an overflow or connecting line (3) for holding liquids, whereby one of the two tanks has a filler (5) for filling with liquid and the line has a cross-section whose dimensions are such that both tanks can be filled essentially simultaneously when filling the tank system via the filler. The overflow or connecting line reaches at least above the highest filling level of the tank with the filler at its highest point.
Patent EP-1582844-A2 (EP)
Inventor: ODAMURA SATOSHI
IPC: H04W88/02
Filed: 2005-03-24
Abstract: A cellular phone, including a GPS signal processing means
and a camera, performs navigation by use of a display device,
the navigation performed through location information detection
means for detecting location information from a picture taken
by the camera, and GPS signal processing means based on location
information detected by the location information detection means.
By determining destination information using GPS on the basis
of information taken by the camera, or by acquiring destination
information and additional information from a server, setting
of destination for subsequent navigation is simplified.
Patent EP-1580087-A2 (EP)
Inventor: FINNEY IAN ANTONY
IPC: B60R21/34
Filed: 2005-03-23
Abstract: A road vehicle 10A with a bonnet or engine compartment 14A and
engine 32A is provided with pedestrian protection structure 42. This is formed
by first assessing the structure of the vehicle 10A to determine the ability of
the structure to provide at least partial absorption of a pre-defined impact to
the vehicle (such as a simulated head or leg impact). The additional structure
42 is mounted on the vehicle 10A to provide partial absorption of the initial
impact, at least sufficient for the vehicle structure to absorb any remaining
energy of impact.
Patent EP-1586374-A2 (EP)
Inventor: PECK BILL J
IPC: C12Q1/68
Filed: 2005-03-29
Abstract: Methods of producing nucleic acid arrays using an  in situ  nucleic acid
synthesis protocol are provided, where the  in situ  nucleic acid synthesis protocol
includes a plurality of cycles, each of which includes: (I) a monomer attachment
step; and (II) a functional group generation step. A feature of the subject
methods is that the functional group generation step is performed by sequentially
flowing a plurality of different fluids across the surface of a substrate (110) in a
manner such that the surface is not contacted with a with a triple phase interface
line. Also provided are the arrays (112) produced using the subject methods, as
well as methods for use of the arrays and kits that include the same.
Patent EP-1728374-A2 (EP)
Inventor: ELAZAR GIDON
IPC: G06F1/00
Filed: 2005-02-02
Abstract: Dans divers modes de réalisation, l'invention concerne un dispositif, un système et un procédé permettant de limiter la distribution et l'utilisation qui en est faites de contenus numériques protégés par des droits d'auteur. Le traitement d'un fichier de données reçu via un réseau de communications tel qu'Internet intervient tant dans l'appareil numérique hôte - ordinateur personnel, assistant numérique, lecteur audio, lecteur vidéo, etc - que dans un très petit module de gestion des droits numériques (DRM) qui est connecté libérable au dispositif hôte. Avec, ce traitement, il est extrêmement difficile à une personne non autorisée d'accéder au contenu du fichier de données et/ou de l'utiliser avec un module DRM non autorisé.
Patent EP-1787288-A2 (EP)
Inventor: FRITSCH JUERGEN
IPC: G10L15/18
Filed: 2005-08-18
Abstract: L'invention concerne des techniques de production automatique de documents structurés à partir de la parole, y compris l'identification de concepts pertinents et leur interprétation. Selon une variante, on décrit un générateur de documents structurés qui utilise un processus intégré pour produire un document textuel structuré (du type rapport médical textuel structuré) sur la base d'un flux audio parlé, lequel peut être reconnu au moyen d'un modèle de langage comprenant plusieurs sous-modèles disposés selon une structure hiérarchique. Chaque sous-modèle peut correspondre . à un concept dont on attend qu'il apparaisse dans le flux audio parlé. Différentes parties de ce flux peuvent être reconnues au moyen de différents sous-modèles. Le document textuel résultant peut avoir une structure hiérarchique qui correspond à la structure hiérarchique des sous-modèles utilisés pour la production du document textuel.
Patent EP-1781698-A2 (EP)
Title: Compositions et methodes d'utilisation de la proteine 4 analogue a l'angiopoietine
Inventor: BUNTING STUART
IPC: C07K14/515
Filed: 2005-07-19
Abstract: Cette invention concerne des compositions d'ANGPTL4 et des procédés d'utilisation de ces compositions, ainsi que des agonistes ou des antagonistes de celles-ci, pour le diagnostic et le traitement de maladies ou de troubles, y compris des procédés permettant de moduler la prolifération cellulaire, l'adhésion de cellules et la migration cellulaire.